Genome-wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosis

Reproductive Biology and Endocrinology

Debabrata Ghosh²  Suneeta Mittal¹  Jayasree Sengupta²  Meraj A Khan² 

[1] Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India;Department of Physiology, All India Institute of Medical Sciences, New Delhi, India

关键词: GSEA;    Gene expression;    Differential display;    Endometriosis;    Computational analysis;   

Others  :  1150059
DOI  :  10.1186/1477-7827-10-84

 received in 2012-07-06, accepted in 2012-08-28,  发布年份 2012

【 摘 要 】

Background

In order to obtain a lead of the pathophysiology of endometriosis, genome-wide expressional analyses of eutopic and ectopic endometrium have earlier been reported, however, the effects of stages of severity and phases of menstrual cycle on expressional profiles have not been examined. The effect of genetic heterogeneity and fertility history on transcriptional activity was also not considered. In the present study, a genome-wide expression analysis of autologous, paired eutopic and ectopic endometrial samples obtained from fertile women (n = 18) suffering from moderate (stage 3; n = 8) or severe (stage 4; n = 10) ovarian endometriosis during proliferative (n = 13) and secretory (n = 5) phases of menstrual cycle was performed.

Methods

Individual pure RNA samples were subjected to Agilent’s Whole Human Genome 44K microarray experiments. Microarray data were validated (P < 0.01) by estimating transcript copy numbers by performing real time RT-PCR of seven (7) arbitrarily selected genes in all samples. The data obtained were subjected to differential expression (DE) and differential co-expression (DC) analyses followed by networks and enrichment analysis, and gene set enrichment analysis (GSEA). The reproducibility of prediction based on GSEA implementation of DC results was assessed by examining the relative expressions of twenty eight (28) selected genes in RNA samples obtained from fresh pool of eutopic and ectopic samples from confirmed ovarian endometriosis patients with stages 3 and 4 (n = 4/each) during proliferative and secretory (n = 4/each) phases.

Results

Higher clustering effect of pairing (cluster distance, cd = 0.1) in samples from same individuals on expressional arrays among eutopic and ectopic samples was observed as compared to that of clinical stages of severity (cd = 0.5) and phases of menstrual cycle (cd = 0.6). Post hoc analysis revealed anomaly in the expressional profiles of several genes associated with immunological, neuracrine and endocrine functions and gynecological cancers however with no overt oncogenic potential in endometriotic tissue. Dys-regulation of three (CLOCK, ESR1, and MYC) major transcription factors appeared to be significant causative factors in the pathogenesis of ovarian endometriosis. A novel cohort of twenty-eight (28) genes representing potential marker for ovarian endometriosis in fertile women was discovered.

Conclusions

Dysfunctional expression of immuno-neuro-endocrine behaviour in endometrium appeared critical to endometriosis. Although no overt oncogenic potential was evident, several genes associated with gynecological cancers were observed to be high in the expressional profiles in endometriotic tissue.

【 授权许可】

   
2012 Khan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Bulun SE: Endometriosis. New Engl J Med 2009, 360:268-279.
• [2]Rogers PAW, D’Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA, Zondervan KT: Priorities for endometriosis research: recommendations from an International consensus workshop. Reprod Sci 2009, 16:335-346.
• [3]Eyster KM, Boles AL, Brannian JD, Hansen KA: DNA microarray analysis of gene expression markers of endometriosis. Fertil Steril 2002, 77:38-42.
• [4]Eyster KM, Klinkova O, Kennedy V, Hansen KA: Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007, 88:1505-1533.
• [5]Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, Rojas J, Herrera R, Grigoriadis D, White E, et al.: Human endometriosis is associated with plasma cells and over expression of B lymphocyte stimulator. Proc Natl Acad Sci (USA) 2007, 104:12451-12456.
• [6]Borghese B, Mondon F, Noel J, Fayt I, Mignot TM, Vaiman D, Chapron C: Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol 2008, 22:2557-2562.
• [7]Zafrakas M, Tarlatzis BC, Streichert T, Pournaropoulos F, Wolfle U, Smeets SJ, Wittek B, Grimbizis G, Brakenhoff RH, Pantel K, et al.: Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential. Int J Mol Med 2008, 21:335-344.
• [8]Khan MA, Sengupta J, Giudice LC, Mittal S, Kumar S, Datta Gupta S, Sharma R, Najwa AR, Ghosh D: cDNA-based transcript analysis of autologous eutopic and ectopic endometrium of women with moderate and severe endometriosis. J Endometriosis 2011, 3:8-33.
• [9]Wu Y, Kajdacsy-Balla A, Strawn E, Basir Z, Halverson G, Jailwala P, Wang Y, Wang X, Ghosh S, Guo SW: Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 2006, 147:232-246.
• [10]Cornillie FJ, Oosterlynck D, Lauweryns JM, Koninckx PR: Deeply infiltrating pelvic endometriosis: histology and clinical significance. Fertil Steril 1990, 53:978-983.
• [11]Vercellini P, Frontino G, Pietropaolo G, Gattei U, Daguati R, Crosignani PG: Deep endometriosis: definition, pathogenesis and clinical management. J Am Assoc Gynecol Laparosc 2004, 11:153-161.
• [12]American Society for Reproductive Medicine: Revised classification of endometriosis 1996. Fertil Steril 1997, 67:817-818.
• [13]Ghosh D, Sharkey AM, Charnock-Jones DS, Smith SK, Sengupta J: Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys. Reproduction 2009, 138:357-370.
• [14]Pan W: A comparative review of statistical methods for discovering differently expressed genes in replicated microarray experiments. Bioinformatics 2002, 18:546-554.
• [15]http://www.broadinstitute.org/gsea/msigdb
• [16]Subramanian A, Tamayo P, Mootha VK, et al.: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci (USA) 2005, 102:15545-15550.
• [17]Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res 2002, 30:e36. 1–10
• [18]Bustin SA: Quantification of mRNA using real time reverse transcription PCR (RT-PCR): trends & problems. J Mol Endocrinol 2002, 29:23-39.
• [19]http://www.ncbi.nlm.nih.gov/geo/GSE37837
• [20]Giudice LC: Elucidating endometrial function in the post-genomic era. Hum Reprod Update 2003, 9:223-235.
• [21]Shai RM: Microarray tools for deciphering complex diseases. Front Biosci 2006, 11:1414-1424.
• [22]Bulun SE, Adashi EY: The physiology and pathology of the female reproductive axis. In Williams Textbook of Endocrinology. 10th edition. Edited by Larsen PR, Kronenberg HM, Melmed S, Polonsky K. WB Saunders, Philadelphia; 2003:587-664.
• [23]Cover TM, Thomas JA: Elements of Information Theory. Wiley, New York; 1991.
• [24]Zhou T, Carlson JM, Doyle J: Mutation, specialization, and hypersensitivity in highly optimized tolerance. Proc Natl Acad Sci (USA) 2002, 99:2049-2054.
• [25]Aghajanova L, Giudice LC: Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci 2011, 18:229-251.
• [26]Shi J, Walker MG: Gene set enrichment analysis (GSEA) for interpreting gene expression profiles. Curr Bioinformtics 2007, 2:133-137.
• [27]Zhao H, Wang Q, Bai C, He K, Pan Y: A cross-study gene set enrichment analysis identifies critical pathways in endometriosis. Reprod Biol Endocrinol 2009, 7:94. BioMed Central Full Text
• [28]Bellet MM, Sassone-Corsi P: Mammalian circadian clock and metabolism – epigenetic link. J Cell Sci 2010, 123:3837-3848.
• [29]Sancar A, Lindsey-Boltz LA, Kang T-H, Reardon JT, Lee JH, Ozturk N: Circadian clock control of the cellular response to DNA damage. FEBS Lett 2010, 584:2618-2625.
• [30]Prieur X, Roszer T, Ricote M: Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta 2010, 1801:327-337.
• [31]Tariverdian N, Theoharides TC, Siedentopf F, Gutierrez G, Jeschke U, Rabinovich GA, Blois SM, Arck PC: Neuro-endocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol 2007, 29:193-210.
• [32]Tariverdian N, Rucke M, Szerkes-Bartho J, Blois SM, Karpf EF, Sedomayr H, Siedentopf F, Arck PC: Neuro-endocrine circuitry and endometriosis: progesterone derivative dampens corticotrophin-releasing hormone-induced inflammation by peritoneal cells in vitro. J Mol Med 2010, 88:267-278.
• [33]Wang G, Tokushige N, Russell P, Dubinovsky S, Markham R, Fraser IS: Neuroendocrine cells in eutopic endometrium of women with endometriosis. Hum Reprod 2010, 25:287-291.
• [34]Asante A, Taylor RN: Endometriosis: the role of neuroangiogenesis. Ann Rev Physiol 2011, 73:163-182.
• [35]Nasu K, Yuge A, Tsuno A, Nishida M, Narahara H: Involvement of resistance to apoptosis in the pathogenesis of endometriosis. Histol Histopathol 2009, 24:1181-1192.
• [36]Gentilini D, Vigano P, Somigliana E, Vicentini LM, Vignali M, Busacca M, Di Blasio AM: Endometrial stromal cells from women with endometriosis reveal peculiar migratory behavior in response to ovarian steroids. Fertil Steril 2010, 93:706-715.
• [37]Stephens AN, Hannan NJ, Rainczuk A, Meehan KL, Chen J, Nicholls PK, Rombauts LJ, Stanton PG, Robertson DM, Salamonsen LA: Post-translational modifications and protein-specific isoforms in endometriosis. J Proteome Res 2010, 9:2438-2449.
• [38]Adachi M, Nasu K, Tsuno A, Kawano Y, Narahara H: Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis. Eur J Obstet Gynecol Reprod Biol 2010, 155:85-88.
• [39]Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, Lin Z: Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol 2005, 95:57-62.
• [40]Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, Husen B, Thole H, Dunselman G, Groothuis P: Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007, 22:3148-3158.
• [41]Smuc T, Hevir N, Ribic-Pucelj M, Husen B, Thole H, Rizner TL: Disturbed estrogen and progesterone action in ovarian endometriosis. Mol Cell Endocrinol 2009, 301:59-64.
• [42]Delvoux B, Groothuis P, D’Hooghe T, Kyama C, Dunselman G, Romano A: Increased production of 17β estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 2009, 94:876-883.
• [43]Colette S, Lousse JC, Defrere S, Curaba M, Heilier JF, Van Langendonckt A, Mestdagt M, Foidart JM, Loumaye E, Donnez J: Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009, 24:2133-2141.
• [44]Val P, Lefrancois-Martinez AM, Veyssiere G, Matinez A: Sf-1 a key player in the development and differentiation of steroidogenic tissues. Nucl Recept 2003, 1:8. BioMed Central Full Text
• [45]Stocco DM: StAR protein and the regulation of steroid hormone biosynthesis. Ann Rev Physiol 2001, 63:193-213.
• [46]Bulun SE, Utsunomiya H, Lin Z, Yin P, Cheng YH, Pavone ME, Tokunaga H, Trukhacheva E, Attar E, Gurates B, et al.: Sterodogenic factor-1 and endometriosis. Mol Cell Endocrinol 2009, 300:104-108.
• [47]Utsunomiya H, Cheng YH, Lin Z, Reierstad S, Yin P, Attar E, Xue Q, Imir G, Thung S, Trukhacheva E, et al.: Upstream stimulatory factor-2 regulates steroidogenic fctor-1 expression in endometriosis. Mol Endocrinol 2007, 22:904-914.
• [48]Tian Y, Kong B, Zhu W, Su S, Kan Y: Expression of steroidogenic factor 1 (SF-1) and steroidogenic acute regulatory protein (StAR) in endometriosis is associated with endometriosis severity. J Int Med Res 2009, 37:1389-1395.
• [49]http://www.genego.com/map_2210.php
• [50]Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, Tokunaga H, Utsunomiya H, Yin P, Luo X, et al.: Estrogen receptor-b, estrogen receptor-a, and progesterone resistance in endometriosis. Semin Reprod Med 2010, 28:36-43.
• [51]Wren JD, Wu Y, Guo SW: A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium. Hum Reprod 2007, 22:2093-2102.
• [52]Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, Painter JN, Missmer SA, Kennedy SH, Zondervan KT: The search for genes contributing to endometriosis risk. Hum Reprod Update 2008, 14:447-457.
• [53]Varma R, Rollason T, Gupta JK, Maher ER: Endometriosis and the neoplastic process. Reproduction 2004, 127:293-304.
• [54]Vlahos NF, Kalampokas T, Fotiou S: Endometriosis and ovarian cancer: a review. Gynecol Endocrinol 2010, 26:213-219.
• [55]Kurman RJ, Shih IM: Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer – shifting the paradigm. Hum Pathol 2011, 42:918-931.
• [56]Melin A, Lundholm C, Malki N, Swahn ML, Sparen P, Bergqvist A: Endometriosis as a prognostic factor for cancer survival. Int J Cancer 2011, 129:948-955.
• [57]Arora S, Bisanz KM, Peralta LA, Basu GD, Choudhary A, Tibes R, Azorsa DO: RNAi screening of kinome identifies modulators of cisplatin response in ovarian cancer cells. Gynecol Oncol 2010, 118:220-227.
• [58]Concin N, Hefler L, van Bavel J, Mueller-Holzner E, Zeimet A, Daxenbichler G, Speiser P, Hacker N, Marth C: Biolgical markers in pT1 and pT2 ovarian cancer with lymph node metastasis. Gynecol Oncol 2003, 89:9-15.
• [59]Katayama M, Sekiguchi K: Laminin-5 in epithelial tumour invasion. J Mol Histol 2004, 35:277-286.
• [60]Perez-Nadales E, Lloyd AC: Essential function for ErbB3 in breast cancer proliferation. Breast Cancer Res 2004, 6:137-139. BioMed Central Full Text
• [61]Carlson JM, Doyle J: Complexity and robustness. Proc Natl Acad Sci (USA) 2002, 99(Suppl. 1):2538-2545.
• [62]Prowse AH, Manek S, Varma R, Liu J, Godwin AK, Maher ER, Tomlinson IP, Kennedy SH: Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer 2006, 119:556-562.
• [63]Kvaskoff M, Mesrine S, Clavel-Chapelon F, Boutron-Rualt MC: Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort. Int J Epidemiol 2009, 38:1143-1153.